Chemours Co (CC) : Mak Capital One reduced its stake in Chemours Co by 9.14% during the most recent quarter end. The investment management company now holds a total of 2,786,841 shares of Chemours Co which is valued at $27.3 Million after selling 280,391 shares in Chemours Co , the firm said in a disclosure report filed with the SEC on May 13, 2016.Chemours Co makes up approximately 22.69% of Mak Capital One’s portfolio.
Other Hedge Funds, Including , Ancora Advisors reduced its stake in CC by selling 25,120 shares or 65.59% in the most recent quarter. The Hedge Fund company now holds 13,180 shares of CC which is valued at $129,296. Chemours Co makes up approx 0.02% of Ancora Advisors’s portfolio.Credit Agricole S A reduced its stake in CC by selling 163,940 shares or 99.2% in the most recent quarter. The Hedge Fund company now holds 1,326 shares of CC which is valued at $13,008.Smithfield Trust Co reduced its stake in CC by selling 76 shares or 6.44% in the most recent quarter. The Hedge Fund company now holds 1,105 shares of CC which is valued at $11,337. Bluecrest Capital Management Ltd added CC to its portfolio by purchasing 115,812 company shares during the most recent quarter which is valued at $1.2 Million. Chemours Co makes up approx 0.10% of Bluecrest Capital Management Ltd’s portfolio.Hall Laurie J Trustee reduced its stake in CC by selling 87 shares or 4.89% in the most recent quarter. The Hedge Fund company now holds 1,691 shares of CC which is valued at $15,422. Chemours Co makes up approx 0.01% of Hall Laurie J Trustee’s portfolio.
Chemours Co opened for trading at $9.31 and hit $9.67 on the upside on Wednesday, eventually ending the session at $9.58, with a gain of 3.79% or 0.35 points. The heightened volatility saw the trading volume jump to 37,66,846 shares. Company has a market cap of $1,738 M.
On the company’s financial health, Chemours Co reported $0.06 EPS for the quarter, based on the information available during the earnings call on May 2, 2016. Analyst had a consensus estimate of $0.06. The company had revenue of $1297.00 million for the quarter, compared to analysts expectations of $1267.06 million. The company’s revenue was down -4.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.33 EPS.
Many Wall Street Analysts have commented on Chemours Co. Company shares were Reiterated by Barclays on May 9, 2016 to “Overweight”, Firm has raised the Price Target to $ 15 from a previous price target of $14 .Chemours Co was Upgraded by Goldman to ” Buy” on Mar 14, 2016. Chemours Co was Downgraded by Jefferies to ” Hold” on Feb 16, 2016.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.